07:00 , Jun 24, 2013 |  BC Week In Review  |  Financial News

Trigemina completes venture financing

Trigemina Inc. , Moraga, Calif.   Business: Neurology   Date completed: 6/17/13   Type: Venture financing   Raised: $4.2 million   Investors: Aurus Bios; individual investors   Note: The financing is a series A-1 round....
07:00 , May 16, 2011 |  BioCentury  |  Emerging Company Profile

Andes: Reinstating Apoptosis

Andes Biotechnologies Inc. has discovered a new family of molecules, non-coding mitochondrial RNA, which are differentially expressed in cancer cells and appear to be involved in the apoptotic pathway. The company hopes that knocking down...